Loading
Latest filing published 08 Jan 2014 for MultiCell Technologies, Inc., €734.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
W. Gerald Newmin appears in our data through filings on MultiCell Technologies, Inc. shares, published by SEC (Form 4). Between 10 March 2006 and 7 January 2014, the trades on record add up to 17 filings.
Purchases make up the whole of the open-market record (2 purchases, €3,470). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 12 share grants. In 2014 alone, the filings show 1 purchase and no sales.
The latest filing, published on 8 January 2014, reports an open-market purchase of €734 in MultiCell Technologies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations